Back to
Man Group plc
GHDX5 quarters
Position history for
Man Group plc's holdings in GENOMIC HEALTH INC
As of its Q3 2019 13F, Man Group held 201,236 shares of GHDX (Genomic Health), worth $13.6M. Man Group's 13F filings listed GHDX from Q4 2018 to Q3 2019, 4 quarterly filings. GHDX was 0.1% of Man Group's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$18M
Total Shares Change
-279,821
Quarter-by-Quarter History
Other major holders of GHDX: BAKER BROS. ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP